Detalhe da pesquisa
1.
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
Mult Scler
; 28(2): 217-227, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048323
2.
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
Neuroimage
; 238: 118225, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062267
3.
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 90(5): 507-513, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30833449
4.
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Brain
; 136(Pt 1): 106-15, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365093
5.
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Mult Scler Relat Disord
; 63: 103894, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636271
6.
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis.
BMJ Open
; 11(11): e050176, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824113
7.
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.
Mult Scler Relat Disord
; 49: 102773, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33540279
8.
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Epilepsia
; 51(9): 1898-901, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20550553
9.
Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling.
Neurol Neuroimmunol Neuroinflamm
; 6(6): e626, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659123
10.
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Acta Neuropathol Commun
; 5(1): 95, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208041
11.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
JAMA Neurol
; 73(8): 954-60, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27366989
12.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Neurology
; 83(17): 1492-9, 2014 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25253748
13.
Hydration and independence in activities of daily living in people with multiple sclerosis: a pilot investigation.
Disabil Rehabil
; 33(19-20): 1822-5, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21231820